4//SEC Filing
Gawlick Rainer 4
Accession 0001437749-20-025799
CIK 0001443669other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:18 PM ET
Size
8.3 KB
Accession
0001437749-20-025799
Insider Transaction Report
Form 4
Proto Labs IncPRLB
Gawlick Ranier
Director
Transactions
- Sale
Common Stock
2020-12-18$160.00/sh−2,000$320,008→ 24,259 total - Exercise/Conversion
Common Stock
2020-12-18$53.34/sh+2,000$106,680→ 26,259 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-18−2,000→ 715 totalExercise: $53.34Exp: 2023-05-23→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
- [F2]Fully vested.
- [F3]Reflects the weighted average price of 2,000 shares of common stock of Proto Labs, Inc. sold by the reporting person on December 18, 2020 with sale prices ranging from $160.00 to $160.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Proto Labs Inc
CIK 0001443669
Entity typeother
Related Parties
1- filerCIK 0001542473
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:18 PM ET
- Size
- 8.3 KB